Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,670.50
Bid: 1,670.00
Ask: 1,670.50
Change: 0.50 (0.03%)
Spread: 0.50 (0.03%)
Open: 1,661.50
High: 1,679.50
Low: 1,658.50
Prev. Close: 1,670.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares, ADSs

Tue, 15th Apr 2014 15:08

LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives, including Chief Executive Andrew Witty, acquired shares and American Depositary Shares under the 2009 deferred annual bonus plan at a price of 1581.50 pence per share and USD53.42 per ADS each following a dividend reinvestment.

Details are as follows.

Sir Andrew Witty

Acquisition of 2,101 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 2,101 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr S Dingemans

Acquisition of 924 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 924 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Dr M M Slaoui

Acquisition of 791 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 791 ADSs under the matching element of the Plan (Company contribution).

 

 

Mr S M Bicknell

Acquisition of 210 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 210 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mrs D P Connelly

Acquisition of 153 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 153 ADSs under the matching element of the Plan (Company contribution).

 

 

Mr R G Connor

Acquisition of 236 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 236 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr S A Hussain

Acquisition of 119 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 119 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr W C Louv

 

Acquisition of 191 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 191 ADSs under the matching element of the Plan (Company contribution).

 

 

Mr D S Redfern

Acquisition of 449 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 449 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Ms C Thomas 

Acquisition of 338 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 338 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr P C Thomson

Acquisition of 69 Ordinary Shares under the personal contribution element of the Plan.

 

 

 

Acquisition of 69 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Mr D E Troy

Acquisition of 350 ADSs under the personal contribution element of the Plan.

 

 

 

Acquisition of 350 ADSs under the matching element of the Plan (Company contribution).

 

 

Dr P J T Vallance

Acquisition of 986 Ordinary Shares under the personal contribution element of the Plan.

 

 

Acquisition of 986 Ordinary Shares under the matching element of the Plan (Company contribution).

 

 

Ms E Walmsley

Acquisition of 544 Ordinary Shares under the personal contribution element of the Plan.

 

 

Acquisition of 544 Ordinary Shares under the matching element of the Plan (Company contribution).

 



Shares in the global healthcare company were trading at 1,549.00 pence up 0.4% Tuesday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.